{"altmetric_id":1439574,"counts":{"readers":{"mendeley":27,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[52244],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"A novel series of 2-aminobenzimidazole inhibitors of BACE1 has been discovered using fragment-based drug discovery (FBDD) techniques. The rapid optimization of these inhibitors using structure-guided medicinal chemistry is discussed.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f6100023f2","authors":["Madden J","Dod JR","Godemann R","Kraemer J","Smith M","Biniszkiewicz M","Hallett DJ","Barker J","Dyekjaer JD","Hesterkamp T"],"doi":"10.1016\/j.bmcl.2010.06.089","first_seen_on":"2013-05-05T11:10:10+00:00","issns":["0960894X"],"issue":"17","journal":"Bioorganic & Medicinal Chemistry Letters","last_mentioned_on":1283175780,"links":["http:\/\/www.sciencedirect.com\/science?_ob=ArticleURL&_udi=B6TF9-50F3V6G-1&_user=10&_coverDate=09%2F01%2F2010&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=76d99d8571ba312e01934deae1deedfd"],"pmid":"20656487","pubdate":"2010-01-09T00:00:00+00:00","publisher":"Elsevier Ltd","publisher_subjects":[{"name":"Medicinal And Biomolecular Chemistry","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Organic Chemistry","scheme":"era"}],"scopus_subjects":["Life Sciences","Chemistry","Pharmacology, Toxicology and Pharmaceutics","Physical Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["chemistry","biochemistry"],"title":"Fragment-based discovery and optimization of BACE1 inhibitors ","type":"article","volume":"20","mendeley_url":"http:\/\/www.mendeley.com\/research\/fragmentbased-discovery-optimization-bace1-inhibitors"},"altmetric_score":{"score":7.12,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.12},"context_for_score":{"all":{"total_number_of_other_articles":4011326,"mean":5.032398260945,"rank":486353,"this_scored_higher_than_pct":87,"this_scored_higher_than":3524434,"rank_type":"exact","sample_size":4011326,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":86727,"mean":6.8622606630154,"rank":13194,"this_scored_higher_than_pct":84,"this_scored_higher_than":73525,"rank_type":"exact","sample_size":86727,"percentile":84},"this_journal":{"total_number_of_other_articles":1423,"mean":2.1211954992968,"rank":56,"this_scored_higher_than_pct":94,"this_scored_higher_than":1348,"rank_type":"exact","sample_size":1423,"percentile":94},"similar_age_this_journal_3m":{"total_number_of_other_articles":33,"mean":1.87,"rank":3,"this_scored_higher_than_pct":87,"this_scored_higher_than":29,"rank_type":"exact","sample_size":33,"percentile":87}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":9,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":10,"Student  > Postgraduate":1,"Student  > Master":3,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":3,"Neuroscience":1,"Chemistry":10,"Agricultural and Biological Sciences":10,"Biochemistry, Genetics and Molecular Biology":1,"Pharmacology, Toxicology and Pharmaceutical Science":1,"Chemical Engineering":1}}},"geo":{"mendeley":{"AR":1,"IT":1,"IN":1}}},"posts":{"blogs":[{"title":"Evotec and BACE","url":"http:\/\/practicalfragments.blogspot.com\/2010\/08\/evotec-and-bace.html","license":"public","citation_ids":[1439574,1439577],"posted_on":"2010-08-30T13:43:00+00:00","summary":"Certain targets seem to be particularly popular with fragment-based methods, perhaps in part because they are recalcitrant to other approaches. One of these is the Alzheimer\u2019s target BACE, as described in a post earlier this year on work from Schering-Plou","author":{"name":"Practical Fragments","url":"http:\/\/practicalfragments.blogspot.com\/","description":"This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments."}}]}}